Halozyme Therapeutics Inc (NASDAQ:HALO)

9.23
Data as of Jul 30
 -0.28 / -2.94%
Today’s Change
6.51
Today|||52-Week Range
18.18
-38.43%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Engler Robert L
Director
Sale5/15/2014126,700$7.56$957.9K+20.50%
Engler Robert L
Director
Buy5/15/2014150,000$4.10$615.0K+20.50%
Falberg Kathryn E
Director
Buy8/14/201350,000$6.91$345.5K+34.55%
Patton John Stuart
Director
Sale9/16/201337,500$9.16$343.5K+1.43%
Patton John Stuart
Director
Sale9/13/201337,500$9.10$341.3K+0.93%
Falberg Kathryn E
Director
Buy8/12/201350,000$6.72$336.0K+34.74%
Shepard H Michael
Chief Scienctific Officer & Vice President
Sale8/19/201310,000$7.11$71.1K+28.19%
Frost Gregory Ian
President & Chief Executive Officer
Buy12/11/201333,113$2.05$67.9K-27.83%
Ramsay David A
Chief Financial Officer & Vice President
Buy9/16/2013130,000$0.39$50.7K+1.43%
Third Security Llc
Sale10/15/201310,000$4.94$49.4K-13.82%
Page of 3

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.